SOLID FOSMETPANTOTENATE FORMULATIONS

Solid formulations comprising a compound having formula (I) or a pharmaceutically acceptable salt thereof, and their use in the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), are provided.

Saved in:
Bibliographic Details
Main Authors Ruby, Kale, Macikenas, Dainius
Format Patent
LanguageEnglish
Published 23.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Solid formulations comprising a compound having formula (I) or a pharmaceutically acceptable salt thereof, and their use in the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), are provided.
Bibliography:Application Number: US201816483652